An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

By Schwartz Thomas   Azhar Nouman   Husain Juhi   Nihalani Nikhil   Simionescu Mihai   Coovert Douglas   Jindal Shefali   Tirmazi Syed  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 17, Iss. 3, 2005-07 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite

Is Tiagabine Helpful in Generalized Anxiety Disorder?

By Balon Richard  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 3, 2007-07 ,pp. : 197-197

Informa Healthcare

Access to resources Recommend Favorite

Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

By Crocq M.A.   Leclercq P.   Guillon M.S.   Bailey P.E.  

European Psychiatry, Vol. 17, Iss. 5, 2002-09 ,pp. : 296-297

Elsevier

Access to resources Recommend Favorite

Open-Label Dosage and Tolerability Study of Tiagabine Monotherapy in Patients with Refractory Complex Partial Seizures

By Schachter S.C.   Cahill W.T.   Wannamaker B.B.   Shu V.S.   Sommerville K.W.  

Journal of Epilepsy, Vol. 11, Iss. 5, 1998-09 ,pp. : 248-255

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of milnacipran in the treatment of generalized anxiety disorder: an open study

By Tsukamoto Tohru   Kondoh Reiko   Ichikawa Keiko  

International Journal of Psychiatry in Clinical Practice, Vol. 8, Iss. 4, 2004-12 ,pp. : 255-258

Ashgate Publishing Ltd

Access to resources Recommend Favorite